Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised 
Standard Chartered Expands Hedge Fund Access for Wealth Clients 
Moody’s Upgrades Vodafone Hybrid Debt Ratings to Baa3 
Samsung Eyes $72 Billion Shareholder Return Plan as AI Chip Boom Fuels Profits 
SpaceX Hires Natural Gas Trader to Meet Growing Energy Needs 
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut 
Amazon to Expand Drone Delivery to 500 U.S. Locations 
Barclays Downgrades Renault as Cost Savings Challenges Grow 
Hyundai Motor Union Launches First Full Strike in Decade Over Wages, AI Job Risks 
Anthropic IPO Could Challenge SpaceX’s Record $86 Billion Offering 
REPAY Stock Rises After Visa Platform Connect Collaboration 
Baidu Shares Sink to One-Year Low as Ad Weakness Overshadows AI Growth 
Unifor Reaches Tentative GM Deal for 4,600 Ontario Workers 
Moody’s Affirms NVIDIA Aa1 Rating as AI Data Center Guarantees Reach $105 Billion 
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars 
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead 
 - EconoTimes)
Add as a preferred source on Google
Dublin, May 08, 2018 -- The "Point-of-Care Diagnostics & Biosensors Europe 2018" conference has been added to ResearchAndMarkets.com's offering.
Point-of-Care Diagnostics Europe 2018 brings together the key opinion leaders from both academia and industry, this annual conference will discuss the expanding Point-of-Care Diagnostics and Global Health fields and provide the most up-to-date presentations from leaders in these fields and offer networking and engagement opportunities with delegates from around the world.
This conference will provide an overview of the point-of-care (POC) testing landscape, from novel technologies to regulatory approval. Experts in these fields will share their views on point-of-care in the clinical setting. The aim of this meeting is to bring together life science researchers that work at the interface between biology and chemistry and technology development to discuss problems, highlight solutions and facilitating collaborations. Also, we frame the role of POC testing in the expanding Global Health field and highlight opportunities existing in many parts of the world.
This conference covers POC Detection, POC Diagnostics and POC-based Treatment Options as part of the Comprehensive Coverage of this Expanding Field. The POC testing field is expanding focused not only on infectious disease diagnostics (which represents 80% of the marketplace) but also with cancer and cardiovascular disease focus. We address each of these segments in this conference.
Agenda:
- Impact of Microfluidics/Lab-on-a-Chip Technologies for Point-of-Care (POC) Diagnostics Applications
- Low Cost POC Diagnostics Platforms for Deployment Worldwide
- POC Diagnostics for Global Health: A Worldwide Perspective
- POC Diagnostics in Cardiovascular Disease Testing
- Point-of-Care Diagnostics in Infectious Disease Testing
- Wearable and Implantable Devices
- Worldwide Regulatory Trends and Hurdles in the Deployment of POC Testing
For more information about this conference visit https://www.researchandmarkets.com/research/nqcksd/european?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biotechnology, Point-of-Care Diagnostics
